Jade Biosciences, Inc. (JBIO)
20.12
-1.28
(-5.98%)
USD |
NASDAQ |
Sep 03, 15:05
Jade Biosciences Total Assets (Quarterly) : 472.11M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 472.11M |
| March 31, 2026 | 319.43M |
| December 31, 2025 | 349.78M |
| September 30, 2025 | 202.45M |
| June 30, 2025 | 223.97M |
| March 31, 2025 | 77.53M |
| December 31, 2024 | 80.33M |
| September 30, 2024 | 90.96M |
| June 30, 2024 | 111.69M |
| March 31, 2024 | 106.82M |
| December 31, 2023 | 127.42M |
| September 30, 2023 | 140.88M |
| Date | Value |
|---|---|
| June 30, 2023 | 155.76M |
| March 31, 2023 | 124.39M |
| December 31, 2022 | 135.30M |
| September 30, 2022 | 147.66M |
| June 30, 2022 | 155.68M |
| March 31, 2022 | 167.00M |
| December 31, 2021 | 175.36M |
| September 30, 2021 | 184.12M |
| June 30, 2021 | 62.43M |
| March 31, 2021 | 9.948M |
| December 31, 2020 | 4.715M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | 392.02M |
| Cue Biopharma, Inc. | 30.71M |
| Praxis Precision Medicines, Inc. | 1.390B |
| Opus Genetics, Inc. | 92.97M |
| Faeth Therapeutics, Inc. | 189.31M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 32.20M |
| Shareholders Equity (Quarterly) | 439.92M |
| Debt to Equity Ratio | 0.0014 |
| Current Ratio | 14.93 |
| Net Debt Paydown Yield | 0.00% |